http://en.nowos.info Sat, 16 Jan 2010 12:27:59 +0000 http://backend.userland.com/rss092 en NewCardio is cardiac diagnostic technology provider, announced that on January 12, 2010, it received notice of allowance for U.S. patent 7,647,093, titled "Apparatus and method for cordless recording and telecommunication transmission of three special ECG leads and their processing," from the U.S. Patent and Trademark Office. This represents the core ... http://en.nowos.info/cardiobip-is-a-unique-hand-held-ecg/ H1N1 swine flu may be fading from the news some, but the number of confirmed cases nationwide has been higher than is usual for seasonal flu in the month of May. What does that mean? Is this flu's ability to linger into the spring suggestive of how different a beast ... http://en.nowos.info/virus-ah1n1/ Developed by QLT's wholly owned subsidiary, QLT USA, Inc., Eligard® formulations are approved in eight countries for the palliative treatment of advanced prostate cancer. Photo of the Eligard product line. Eligard is a leuprolide acetate product—a luteinizing hormone-releasing hormone (LHRH) agonist. Sustained levels of leuprolide decrease testosterone levels to inhibit tumor ... http://en.nowos.info/eligard/ Visudyne® (verteporfin) was the first therapeutic treatment approved worldwide for certain forms of wet age-related macular degeneration (AMD), the leading cause of blindness in people over the age of 55. Visudyne is commercially available in more than 75 countries for the treatment of predominantly classic subfoveal choroidal neovascularization (CNV) and in ... http://en.nowos.info/visudyne/ A 42-year-old HIV patient with leukemia appears to have no detectable HIV in his blood and no symptoms after a stem cell transplant from a donor carrying a gene mutation that confers natural resistance to the virus that causes AIDS, according to a report published Wednesday in the New England ... http://en.nowos.info/without-hiv/ CELATOR® PHARMACEUTICALS PRESENTS PHASE 1 RESULTS WITH CPX-351 IN PATIENTS WITH ADVANCED LEUKEMIA AT THE AMERICAN SOCIETY OF HEMATOLOGY MEETING Findings confirm advantages of fixed-ratio drug delivery and lay the groundwork for Phase 2 trials already underway in first-line and first-relapse Acute Myeloid Leukemia (AML) settings Today Celator Pharmaceuticals announced that a Phase ... http://en.nowos.info/celator-pharmaceuticals-presents-phase-1-results-with-cpx-351/ Pfizer announced the results of an observational study that showed patients taking Lipitor® (atorvastatin calcium) had a significant 13 percent reduction in the relative risk of experiencing a cardiovascular event compared with patients taking simvastatin (Zocor®) therapy. The patients in this study did not have evident cardiovascular disease and were ... http://en.nowos.info/patients-taking-lipitor-had-a-significantly-reduced-risk-of-cardiovascular-events-compared-with-patients-taking-simvastatin-new-observational-study-shows/ In Friday shares of Sunrise Assisted Living (SRZ) jumped 74 % to $ 0.99. But shares of Sunrise Assisted Living worth $ 31.98 year ago. In Friday Sunrise Senior Living announced the receipt of approximately $8.3 million of proceeds resulting from the refinancing of the existing debt of one of its ... http://en.nowos.info/shares-of-sunrise-assisted-living-jumped-74/